Provided by Tiger Fintech (Singapore) Pte. Ltd.

SHANDONG XINHUA

7.220
-0.030-0.41%
Volume:982.00K
Turnover:7.07M
Market Cap:4.98B
PE:9.57
High:7.250
Open:7.220
Low:7.160
Close:7.250
52wk High:9.460
52wk Low:4.895
Shares:690.00M
HK Float Shares:195.00M
Volume Ratio:0.43
T/O Rate:0.50%
Dividend:0.27
Dividend Rate:3.79%
EPS(LYR):0.755
ROE:7.59%
ROA:3.06%
PB:0.88
PE(LYR):9.57
PS:0.54

Loading ...

Xinhua Pharmaceutical Gets Registration Certificate for Osteoporosis Drug

MT Newswires Live
·
Oct 31

Xinhua Pharmaceutical (00719.HK, 000756.SZ) Secures Drug Registration Certificate for Alendronate Sodium Oral Solution

Bulletin Express
·
Oct 31

SHANDONG XINHUA (00719) Receives NMPA Approval for Alendronate Sodium Oral Solution

Stock News
·
Oct 31

AH Premium Rate Statistics as of October 27

Stock News
·
Oct 27

Shandong Xinhua Pharma Renews Trademark Licence with Hualu; Shares Down 3%

MT Newswires Live
·
Oct 27

Hong Kong Stocks Movement | SHANDONG XINHUA (00719) Drops Over 3% Post Earnings, Net Profit for Q1-Q3 Declines 25.53% Year-on-Year

Stock News
·
Oct 27

Shandong Xinhua Pharmaceutical (SEHK:719) Margin Decline Reinforces Investor Concerns on Dividend Sustainability

Simply Wall St.
·
Oct 26

Xinhua Pharmaceutical's Profit Slips 26% in Q1-Q3

MT Newswires Live
·
Oct 24

Shandong Xinhua Pharmaceutical (00719) Releases 2025 Third Quarter Results, Shows Stable Revenue but Lower Net Profit

Bulletin Express
·
Oct 24

Shandong Xinhua Pharmaceutical Company Limited Announces Revised Articles of Association

Bulletin Express
·
Oct 24

Shandong Xinhua Pharmaceutical (00719) Announces EGM Resolutions and Supervisory Committee Cessation

Bulletin Express
·
Oct 24

Shandong Xinhua Pharmaceutical (00719) Announces Renewal of Trademark Licence Agreement

Bulletin Express
·
Oct 24

SHANDONG XINHUA (00719) Reports a 25.53% Year-on-Year Decline in Net Profit to 256 Million Yuan in Q3

Stock News
·
Oct 24

Xinhua Pharmaceutical Gets Registration Certificate for Heart Disease Drug in China

MT Newswires Live
·
Oct 13

SHANDONG XINHUA (00719) Receives Drug Registration Certificate for Bisoprolol Fumarate Tablets

Stock News
·
Oct 13

Xinhua Pharmaceutical Gets Trial Approval for Hypertension Drug in China

MT Newswires Live
·
Sep 25

SHANDONG XINHUA (00719): LXH-1211 Tablet Receives Drug Clinical Trial Approval Notice

Stock News
·
Sep 25

AH Stock Premium Statistics | September 19

Stock News
·
Sep 19

Xinhua Pharmaceutical, Unit Obtain Registration Certificates for Two Drugs in China

MT Newswires Live
·
Sep 16

SHANDONG XINHUA (00719) Receives Drug Registration Certificate for Ursodeoxycholic Acid Capsules

Stock News
·
Sep 16